The use of artificial intelligence (AI) to advance stem cell therapy has produced exciting results, with a key role in driving recent growth and innovation. Separated into three parts, this article ...

New Phase 1/2 data support the potential of our CAR T-cell therapy candidates, GLPG5101 and GLPG5201, in addressing unmet needs for patients with poor prognoses. Our innovative decentralized cell ...

Standardized Stem Cell Care Delivers Measurable, Affordable, and Life-Changing Results Across the U.S. DALLAS, Oct. 22, 2025 /PRNewswire/ -- Life Sciences Review has recognized Innovations Stem Cell ...

SAN DIEGO--(BUSINESS WIRE)--Cell Applications, Inc. is pioneering a new era with the release of Brown Fat Preadipocytes (i-HBrPAd), a first-of-its-kind cellular model derived from pluripotent stem ...

Cell culture is a ubiquitous technique used in laboratories across a diverse range of fields and sectors. There is a growing need to standardize and streamline workflows, to ensure the reliability and ...

COLUMBIA, Md., Oct. 2, 2025 /PRNewswire/ -- The Maryland Stem Cell Research Commission (the Commission) awarded $4,707,142 in grant funding to accelerate the development of innovative stem cell–based ...

Beginning with a brief historical overview of CRISPR, we will trace its evolution to the current state of gene engineering, highlighting its pivotal role in reshaping the landscape of molecular ...

FREDERICK, Md., April 15, 2025 /PRNewswire/ -- Nikon CeLL innovation Co., Ltd. (NCLi), a subsidiary of Nikon Corporation has entered into a strategic licensing agreement with RoosterBio, Inc.